Human immunodeficiency virus-associated lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

K Hübel; M Bower; I Aurer; M Bastos-Oreiro; C Besson; U Brunnberg; C Cattaneo; S Collins; K Cwynarski; A Dalla Pria; M Hentrich; C Hoffmann; M J Kersten; S Montoto; J T Navarro; E Oksenhendler; A Re; J-M Ribera; P Schommers; B von Tresckow; C Buske; M Dreyling; A Davies; EHA and ESMO Guidelines Committees. Electronic address: guidelines@ehaweb.org

doi:10.1016/j.annonc.2024.06.003

Human immunodeficiency virus-associated lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Ann Oncol. 2024 Oct;35(10):840-859. doi: 10.1016/j.annonc.2024.06.003. Epub 2024 Sep 3.

Authors

K Hübel¹, M Bower², I Aurer³, M Bastos-Oreiro⁴, C Besson⁵, U Brunnberg⁶, C Cattaneo⁷, S Collins⁸, K Cwynarski⁹, A Dalla Pria², M Hentrich¹⁰, C Hoffmann¹¹, M J Kersten¹², S Montoto¹³, J T Navarro¹⁴, E Oksenhendler¹⁵, A Re⁷, J-M Ribera¹⁴, P Schommers¹, B von Tresckow¹⁶, C Buske¹⁷, M Dreyling¹⁸, A Davies¹⁹; EHA and ESMO Guidelines Committees. Electronic address: guidelines@ehaweb.org

Affiliations

¹ Department of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
² National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
³ Department of Internal Medicine, University Hospital Centre, Zagreb; Medical School, University of Zagreb, Zagreb, Croatia.
⁴ Department of Hematology, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
⁵ Department of Clinical Haematology, Versailles Hospital, Versailles; UVSQ, Université Paris-Saclay, UFR Santé Simone Veil, Inserm, CESP, Villejuif, France.
⁶ Department of Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany.
⁷ Department of Medical Oncology, Division of Hematology, ASST - Spedali Civili, Brescia, Italy.
⁸ HIV i-BASE, London.
⁹ Department of Haematology, University College Hospital, London, UK.
¹⁰ Department of Hematology and Oncology, Red Cross Hospital Munich, Ludwig Maximilian University, Munich.
¹¹ ICH Study Center, Hamburg, Germany.
¹² Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
¹³ Department of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
¹⁴ Department of Hematology, Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
¹⁵ Department of Clinical Immunology, Hôpital Saint-Louis, APHP, Paris, France.
¹⁶ Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen.
¹⁷ Institute of Experimental Cancer Research, Department of Internal Medicine III, Ulm Medical University, Ulm.
¹⁸ Department of Medicine III, Ludwig-Maximilians-University, Munich, Germany.
¹⁹ General Hospital, University Hospital NHS Trust, Southampton, UK.

PMID: 39232987
DOI: 10.1016/j.annonc.2024.06.003

No abstract available

Keywords: EHA–ESMO guideline; diagnosis; human immunodeficiency virus (HIV); lymphoma; treatment.

Publication types

Practice Guideline

MeSH terms

Follow-Up Studies
HIV Infections* / complications
HIV Infections* / diagnosis
HIV Infections* / drug therapy
HIV Infections* / virology
Humans
Lymphoma, AIDS-Related / diagnosis
Lymphoma, AIDS-Related / drug therapy
Lymphoma, AIDS-Related / therapy
Lymphoma, AIDS-Related / virology
Neoplasm Staging